SBRA logo

Sabra Health Care REIT (SBRA) EBITDA

Annual EBITDA

$412.61 M
+$100.80 M+32.33%

December 31, 2024


Summary


Performance

SBRA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSBRAprofitabilitymetrics:

Quarterly EBITDA

$117.47 M
+$15.76 M+15.49%

December 31, 2024


Summary


Performance

SBRA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSBRAprofitabilitymetrics:

TTM EBITDA

$412.61 M
+$29.00 M+7.56%

December 31, 2024


Summary


Performance

SBRA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSBRAprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

SBRA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+32.3%--
3 y3 years+148.2%+150.3%+148.2%
5 y5 years+8.4%+150.3%+148.2%

SBRA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+148.2%at high+1778.3%at high+148.2%
5 y5-year-0.9%+148.2%at high+285.6%-14.5%+148.2%
alltimeall time-33.5%+491.5%-58.8%+285.6%-44.8%+2663.5%

Sabra Health Care REIT EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$412.61 M(+32.3%)
$117.47 M(+15.5%)
$412.61 M(+7.6%)
Sep 2024
-
$101.71 M(+6.6%)
$383.61 M(+13.3%)
Jun 2024
-
$95.41 M(-2.7%)
$338.65 M(+0.4%)
Mar 2024
-
$98.03 M(+10.8%)
$337.23 M(+8.2%)
Dec 2023
$311.81 M(+43.8%)
$88.47 M(+55.9%)
$311.81 M(+44.1%)
Sep 2023
-
$56.75 M(-39.6%)
$216.34 M(+17.2%)
Jun 2023
-
$93.98 M(+29.4%)
$184.61 M(+3.5%)
Mar 2023
-
$72.61 M(-1137.4%)
$178.38 M(-17.8%)
Dec 2022
$216.89 M(+30.5%)
-$7.00 M(-128.0%)
$216.89 M(-19.9%)
Sep 2022
-
$25.01 M(-71.5%)
$270.82 M(-16.8%)
Jun 2022
-
$87.76 M(-21.0%)
$325.41 M(+86.6%)
Mar 2022
-
$111.11 M(+136.8%)
$174.36 M(+4.9%)
Dec 2021
$166.21 M(-60.1%)
$46.93 M(-41.0%)
$166.21 M(-25.9%)
Sep 2021
-
$79.60 M(-225.8%)
$224.45 M(-10.3%)
Jun 2021
-
-$63.29 M(-161.5%)
$250.28 M(-39.4%)
Mar 2021
-
$102.97 M(-2.1%)
$413.12 M(-0.8%)
Dec 2020
$416.29 M(+9.4%)
$105.17 M(-0.2%)
$416.29 M(-1.7%)
Sep 2020
-
$105.44 M(+5.9%)
$423.43 M(+2.2%)
Jun 2020
-
$99.55 M(-6.2%)
$414.45 M(-14.1%)
Mar 2020
-
$106.13 M(-5.5%)
$482.52 M(+26.8%)
Dec 2019
$380.58 M(-38.7%)
$112.31 M(+16.4%)
$380.58 M(+13.5%)
Sep 2019
-
$96.46 M(-42.5%)
$335.35 M(-8.4%)
Jun 2019
-
$167.62 M(+3903.4%)
$366.19 M(-24.3%)
Mar 2019
-
$4.19 M(-93.8%)
$483.55 M(-22.8%)
Dec 2018
$620.61 M(+71.8%)
$67.08 M(-47.3%)
$626.17 M(-16.2%)
Sep 2018
-
$127.29 M(-55.3%)
$747.36 M(+8.9%)
Jun 2018
-
$284.98 M(+94.1%)
$686.08 M(+50.8%)
Mar 2018
-
$146.81 M(-22.0%)
$454.85 M(+25.7%)
DateAnnualQuarterlyTTM
Dec 2017
$361.34 M(+76.6%)
$188.27 M(+185.2%)
$361.98 M(+57.3%)
Sep 2017
-
$66.01 M(+22.8%)
$230.07 M(+3.4%)
Jun 2017
-
$53.75 M(-0.3%)
$222.42 M(-6.9%)
Mar 2017
-
$53.94 M(-4.3%)
$238.96 M(+17.2%)
Dec 2016
$204.60 M(+1.1%)
$56.37 M(-3.4%)
$203.97 M(-1.8%)
Sep 2016
-
$58.36 M(-17.0%)
$207.67 M(+4.4%)
Jun 2016
-
$70.30 M(+271.1%)
$198.82 M(+14.3%)
Mar 2016
-
$18.94 M(-68.5%)
$173.90 M(-14.1%)
Dec 2015
$202.43 M(+47.5%)
$60.07 M(+21.3%)
$202.43 M(+4.7%)
Sep 2015
-
$49.52 M(+9.1%)
$193.35 M(+6.6%)
Jun 2015
-
$45.38 M(-4.4%)
$181.34 M(+5.7%)
Mar 2015
-
$47.47 M(-6.9%)
$171.50 M(+25.0%)
Dec 2014
$137.20 M(+27.7%)
$50.99 M(+36.0%)
$137.20 M(+15.9%)
Sep 2014
-
$37.50 M(+5.5%)
$118.34 M(+6.9%)
Jun 2014
-
$35.55 M(+170.0%)
$110.66 M(+19.2%)
Mar 2014
-
$13.16 M(-59.0%)
$92.81 M(-13.6%)
Dec 2013
$107.46 M(+27.8%)
$32.13 M(+7.8%)
$107.46 M(+11.0%)
Sep 2013
-
$29.82 M(+68.4%)
$96.85 M(+9.0%)
Jun 2013
-
$17.70 M(-36.3%)
$88.83 M(-4.0%)
Mar 2013
-
$27.80 M(+29.2%)
$92.51 M(+10.0%)
Dec 2012
$84.11 M(+20.6%)
$21.52 M(-1.3%)
$84.11 M(-0.7%)
Sep 2012
-
$21.81 M(+2.0%)
$84.71 M(+6.3%)
Jun 2012
-
$21.38 M(+10.2%)
$79.72 M(+7.4%)
Mar 2012
-
$19.41 M(-12.3%)
$74.23 M(+6.4%)
Dec 2011
$69.75 M
$22.12 M(+31.5%)
$69.75 M(+46.4%)
Sep 2011
-
$16.82 M(+5.9%)
$47.63 M(+54.6%)
Jun 2011
-
$15.88 M(+6.4%)
$30.81 M(+106.4%)
Mar 2011
-
$14.93 M
$14.93 M

FAQ

  • What is Sabra Health Care REIT annual EBITDA?
  • What is the all time high annual EBITDA for Sabra Health Care REIT?
  • What is Sabra Health Care REIT annual EBITDA year-on-year change?
  • What is Sabra Health Care REIT quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Sabra Health Care REIT?
  • What is Sabra Health Care REIT TTM EBITDA?
  • What is the all time high TTM EBITDA for Sabra Health Care REIT?

What is Sabra Health Care REIT annual EBITDA?

The current annual EBITDA of SBRA is $412.61 M

What is the all time high annual EBITDA for Sabra Health Care REIT?

Sabra Health Care REIT all-time high annual EBITDA is $620.61 M

What is Sabra Health Care REIT annual EBITDA year-on-year change?

Over the past year, SBRA annual EBITDA has changed by +$100.80 M (+32.33%)

What is Sabra Health Care REIT quarterly EBITDA?

The current quarterly EBITDA of SBRA is $117.47 M

What is the all time high quarterly EBITDA for Sabra Health Care REIT?

Sabra Health Care REIT all-time high quarterly EBITDA is $284.98 M

What is Sabra Health Care REIT TTM EBITDA?

The current TTM EBITDA of SBRA is $412.61 M

What is the all time high TTM EBITDA for Sabra Health Care REIT?

Sabra Health Care REIT all-time high TTM EBITDA is $747.36 M